Your browser doesn't support javascript.
loading
Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study.
Süto, Gábor; Molnár, Gergo A; Rokszin, Gyorgy; Fábián, Ibolya; Kiss, Zoltan; Szekanecz, Zoltán; Poór, Gyula; Jermendy, György; Kempler, Peter; Wittmann, István.
Afiliação
  • Süto G; Second Department of Medicine and Nephrology-Diabetes Centre, University of Pécs Medical School, Pécs, Hungary.
  • Molnár GA; Second Department of Medicine and Nephrology-Diabetes Centre, University of Pécs Medical School, Pécs, Hungary.
  • Rokszin G; RxTarget Ltd, Szolnok, Hungary.
  • Fábián I; RxTarget Ltd, Szolnok, Hungary.
  • Kiss Z; Second Department of Medicine and Nephrology-Diabetes Centre, University of Pécs Medical School, Pécs, Hungary.
  • Szekanecz Z; Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Poór G; National Institute of Rheumatology and Physiotherapy, Budapest, Hungary.
  • Jermendy G; Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
  • Kempler P; First Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Wittmann I; Second Department of Medicine and Nephrology-Diabetes Centre, University of Pécs Medical School, Pécs, Hungary istvan.wittmann@aok.pte.hu.
Article em En | MEDLINE | ID: mdl-33472796

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2021 Tipo de documento: Article